Neovasc Inc. 5Y Revenue Growth (per Share)

5Y Revenue Growth (per Share) of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including 5Y Revenue Growth (per Share) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 5Y Revenue Growth (per Share) for 2021 was -80.48% (a 6.06% increase from previous year)
  • Annual 5Y Revenue Growth (per Share) for 2020 was -75.88% (a 2.57% increase from previous year)
  • Annual 5Y Revenue Growth (per Share) for 2019 was -73.98% (a 12.95% increase from previous year)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 5Y Revenue Growth (per Share) of Neovasc Inc.

Most recent 5Y Revenue Growth (per Share)of NVCN including historical data for past 10 years.

Interactive Chart of 5Y Revenue Growth (per Share) of Neovasc Inc.

Neovasc Inc. 5Y Revenue Growth (per Share) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -80.48%
2020 -75.88%
2019 -73.98%
2018 -65.5%
2017 -16.66%
2016 412.31%
2015 315.05%
2014 283.99%
2013 189.66%
2012 20.7%
2011 -2.6%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.